gabapentin has been researched along with Diffuse Parenchymal Lung Disease in 1 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gabapentin, a neurotransmitter modulator, is thought to treat refractory cough associated with interstitial lung disease by improving cough hypersensitivity." | 9.51 | The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial. ( Gao, R; Pu, J; Shi, C; Tang, J; Wang, S; Wang, X; Wen, S; Xu, X; Yu, L; Zhu, Y, 2022) |
| "Gabapentin, a neurotransmitter modulator, is thought to treat refractory cough associated with interstitial lung disease by improving cough hypersensitivity." | 5.51 | The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial. ( Gao, R; Pu, J; Shi, C; Tang, J; Wang, S; Wang, X; Wen, S; Xu, X; Yu, L; Zhu, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, R | 1 |
| Xu, X | 1 |
| Wang, S | 1 |
| Pu, J | 1 |
| Shi, C | 1 |
| Wen, S | 1 |
| Zhu, Y | 1 |
| Tang, J | 1 |
| Wang, X | 1 |
| Yu, L | 1 |
1 trial available for gabapentin and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial.
Topics: Cough; Double-Blind Method; Gabapentin; Humans; Lung Diseases, Interstitial; Prospective Studies; Qu | 2022 |